Achieving Unique Synergies In Antibody Expression

Shortening timelines to generate more productive, stable and high expressing cell lines is the goal of any cell line development program. View the technical poster to learn how combining Catalent’s GPEx® cell line development technology with Berkeley Lights, Inc.’s Beacon® platform for clonal cell line selection resulted in stable, higher-expressing clones in a shortened time frame. 

Click here to download Poster